TruNorth Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-250
Closed -$77.9K 358
2025
Q1
$77.9K Buy
+250
New +$73.8K 0.02% 163

Other funds holding AMGN

TruNorth Capital Management's AMGN Position: Q2 2025 in Review

TruNorth Capital Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 250 shares — an estimated $77.9K sold.

TruNorth Capital Management first reported a position in AMGN in Q1 2025 and held it in 1 quarter. The position peaked at $77.9K in Q1 2025. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • TruNorth Capital Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • TruNorth Capital Management sold 250 Amgen shares in Q2 2025, an estimated $77.9K.
  • TruNorth Capital Management first reported a position in Amgen in Q1 2025 and held it in 1 quarter.
  • TruNorth Capital Management's Amgen position peaked at $77.9K in Q1 2025.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on TruNorth Capital Management's 13F filing for Q2 2025, filed 18 Jul 2025.